MITCHELL DEAN J — SEC insider filings
SEC reporting owner CIK 1199297. 47 insider filings on record with FilingPulse; latest filed 2026-09-24.
Transaction summary — filings shown
Covers all 47 filings on record, filed 2020-10-01 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 100,000 shares, $122,252 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 101.
- Largest priced transaction: purchase of 25,000 shares @ $1.81 ($45,188) in Praxis Precision Medicines, Inc., filed 2022-06-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. (PRAX) | Director | 9 | 2 legs · 75,000 sh · $87,002 | — | 13 |
| PRECIGEN, INC. (PGEN) | Director | 10 | 1 leg · 25,000 sh · $35,250 | — | 22 |
| ImmunoGen, Inc. (IMGN) | Director | 17 | — | — | 36 |
| Theravance Biopharma, Inc. (TBPH) | Director | 7 | — | — | 23 |
| Kinnate Biopharma Inc. (KNTE) | Director | 4 | — | — | 7 |
Insider filings — MITCHELL DEAN J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Disposition to issuer (D): 91,204 · Disposition to issuer (D): 6,009 · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · +5 more | EDGAR |
| 2026-06-16 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 6,009 @ $0 · Grant/award (A): 13,398 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 1,371 @ $0 · Grant/award (A): 648 (derivative) @ $0 | EDGAR |
| 2025-09-25 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Option exercise (M): 1,932 @ $14.36 · Option exercise (M): 8,566 @ $44.25 · Option exercise (M): 1,753 @ $44.04 · Option exercise (M): 1,932 (derivative) @ $0 · Option exercise (M): 8,566 (derivative) @ $0 · Option exercise (M): 1,753 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 10,520 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 10,649 @ $0 · Grant/award (A): 24,258 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 8,566 (derivative) @ $0 | EDGAR |
| 2024-05-10 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 10,537 @ $0 · Grant/award (A): 23,576 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | Kinnate Biopharma Inc. (KNTE) | Disposition to issuer (D): 121,503 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2024-03-18 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 39,510 @ $1.43 · Grant/award (A): 87,412 (derivative) @ $0 · Grant/award (A): 101,626 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 106,837 · Option exercise (M): 106,837 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | ImmunoGen, Inc. (IMGN) | Disposition to issuer (D): 103,000 · Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 142,667 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · +3 more | EDGAR |
| 2023-12-19 | 4/A | ImmunoGen, Inc. (IMGN) | Option exercise (M): 10,000 @ $14.70 | EDGAR |
| 2023-09-26 | 4 | ImmunoGen, Inc. (IMGN) | Option exercise (M): 10,000 @ $14.70 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2023-09-25 | 4 | PRECIGEN, INC. (PGEN) | Purchase (P): 25,000 @ $1.41 | EDGAR |
| 2023-06-16 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 13,090 (derivative) @ $0 · Grant/award (A): 19,597 (derivative) @ $0 | EDGAR |
| 2023-06-14 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 28,981 (derivative) @ $0 | EDGAR |
| 2023-06-13 | 4 | Kinnate Biopharma Inc. (KNTE) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-05-04 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 9,132 @ $0 · Grant/award (A): 22,044 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Purchase (P): 50,000 @ $0.84 | EDGAR |
| 2023-03-13 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 48,290 @ $1.17 · Grant/award (A): 106,837 (derivative) @ $0 · Grant/award (A): 125,489 (derivative) @ $0 | EDGAR |
| 2023-02-24 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 61,576 · Option exercise (M): 61,576 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 3,024 (derivative) @ $0 | EDGAR |
| 2022-10-04 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 3,138 (derivative) @ $0 | EDGAR |
| 2022-07-05 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 3,333 (derivative) @ $0 | EDGAR |
| 2022-06-17 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 44,000 (derivative) @ $3.37 | EDGAR |
| 2022-06-15 | 4 | Kinnate Biopharma Inc. (KNTE) | Grant/award (A): 20,250 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Purchase (P): 25,000 @ $1.81 | EDGAR |
| 2022-05-27 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 22,753 (derivative) @ $0 | EDGAR |
| 2022-04-28 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 9,852 @ $0 · Grant/award (A): 28,000 (derivative) @ $0 | EDGAR |
| 2022-04-04 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 3,151 (derivative) @ $0 | EDGAR |
| 2022-03-29 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 16,212 · Option exercise (M): 16,212 (derivative) @ $0 | EDGAR |
| 2022-02-24 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 27,832 @ $2.03 · Grant/award (A): 61,576 (derivative) @ $0 · Grant/award (A): 83,189 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 1,819 (derivative) @ $0 | EDGAR |
| 2021-10-01 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 2,380 (derivative) @ $0 | EDGAR |
| 2021-09-03 | 4 | ImmunoGen, Inc. (IMGN) | Option exercise (M): 5,000 @ $1.84 · Option exercise (M): 10,000 @ $4.64 · Option exercise (M): 18,000 @ $2.10 · Option exercise (M): 50,000 @ $4.56 · Option exercise (M): 5,000 (derivative) @ $1.84 · Option exercise (M): 10,000 (derivative) @ $4.64 · +2 more | EDGAR |
| 2021-07-02 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 2,048 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 44,000 (derivative) @ $6.77 | EDGAR |
| 2021-06-14 | 4 | Kinnate Biopharma Inc. (KNTE) | Grant/award (A): 20,250 (derivative) @ $0 | EDGAR |
| 2021-06-09 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 22,343 (derivative) @ $0 | EDGAR |
| 2021-04-29 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 9,828 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2021-04-02 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 1,666 (derivative) @ $0 | EDGAR |
| 2021-03-29 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 7,328 @ $7.71 · Grant/award (A): 16,212 (derivative) @ $0 · Grant/award (A): 22,107 (derivative) @ $0 | EDGAR |
| 2021-03-16 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 62,189 · Option exercise (M): 62,189 (derivative) @ $0 | EDGAR |
| 2021-03-05 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 2,968 @ $5.69 · Option exercise (M): 2,968 (derivative) @ $0 | EDGAR |
| 2021-01-04 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 2,093 (derivative) @ $0 | EDGAR |
| 2020-10-01 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 3,750 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1199297 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs